Skip to main content

    Shionogi & Co., Ltd. - Tender offer for shares in UMN Pharma Inc.

Leading Japanese law firm Nishimura & Asahi advised Japanese pharmaceutical company Shionogi & Co., Ltd. (“Shionogi”) [TSE: 4507] on the launch of its tender offer for the common shares and share options of UMN Pharma Inc. (“UMN Pharma”) [TSE: 4585], a vaccine developer based in Akita prefecture, as a part of a transaction to make UMN Pharma a wholly-owned subsidiary of Shionogi.

The Nishimura & Asahi team advising Shionogi was led by partner Yuichiro Hirota, counsel Mitsutoshi Sugihara, and associates Yasuna Itane, Satoshi Omura, Haruhi Abe, Hiroki Azuma, and Sakurako Tojo.

People

廣田 雄一郎

Yuichiro has been the co-head of our Osaka office since its establishment. After studying in the United States and being seconded to the Bank of Japan, he has mainly handled corporate, M&A, cross-border M&A, labor law, and labor dispute matters, and has extensive experience in a variety of other practice areas. In addition, he also regularly consults with his clients in order to ensure that any urgent matters are addressed promptly. His ability to advise on corporate crisis management and M&A matters is enhanced by his close relationships with his clients as well as with other legal professionals.